BioMarin Pharmaceutical Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $1.26B | $4.02B | $408.3M |
| FY2017 | $1.82B | $4.63B | $598.0M |
| FY2018 | $1.46B | $4.43B | $494.0M |
| FY2019 | $1.57B | $4.69B | $437.4M |
| FY2020 | $1.74B | $5.85B | $649.2M |
| FY2021 | $1.74B | $6.00B | $587.3M |
| FY2022 | $1.77B | $6.38B | $724.5M |
| FY2023 | $1.89B | $6.84B | $755.1M |
| FY2024 | $1.33B | $6.99B | $942.8M |
| FY2025 | $1.51B | $7.59B | $1.31B |